Agios shareholders elect directors, approve say-on-pay, ratify PwC at 2022 annual meeting

AGIOS PHARMACEUTICALS, INC.

Elected Jacqualyn A. Fouse, David Scadden, David P. Schenkein as class III directors (48.5M, 48.5M, 45.4M votes for).
Advisory vote on executive compensation approved: 45.0M for, 4.5M against, 9K abstain.
Shareholders recommended say-on-pay every 1 year (48.7M votes); Board adopts annual frequency.
Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022: 50.6M for, 140K against.
Broker non-votes of 1.17M on director elections and advisory items.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.